Clinical Trial Update: Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of spironolactone on insulin resistance in patients with chronic heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Aldactone (spironolactone)

Snippet

Sponsor: Tottori University Hospital | Conditions: Chronic Stable Heart Failure | Phase 4 | Status: COMPLETED